Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

1(17%)

Results Posted

50%(2 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

terminated117%

active_not_recruiting117%

completed467%

Recent Activity

1 active trials

Showing 5 of 6

active_not_recruiting

Clinical Trials (6)

Showing 6 of 6 trials

NCT02076217

Quick Start of Highly Effective Contraception

Active Not Recruiting

NCT05742503

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

Completed

NCT00563576Not Applicable

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Completed

NCT03377608

Modifiers of Tenofovir in the Female Genital Tract

Completed

NCT02146248Not Applicable

HSG and Tubal Patency Study

Completed

NCT01750476

Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

Terminated

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6